Additionally, we identified miR-637 as a target of PANDAR in thyroid gland carcinoma, and PANDAR can be used as a novel therapeutic target for the treatment of thyroid gland carcinoma. The gene discussed is PANDAR; the disease is thyroid gland carcinoma.